• Ouhai, Wenzhou, Zhejiang China
  • 24/7 Service

Top-Tier Hospitals

9000+ Beds Combined

World-Renowned Doctors

Transplant Pioneers

Dedicated Care Team

Satisfied Patients
Call Us : +86 18357823575

Prof. Fengxi Su, MD

Prof. Fengxi Su, MD

Breast Cancer Specialist
  • Specialty :
    Personalized, comprehensive diagnosis and treatment of breast cancer; full-continuum management of breast tumors; diagnosis and treatment of complex breast cases.
  • Affiliated Hospital :
    Guangzhou Concord Cancer Center
  • Department :
    Breast Cancer Department
  • Language :
    English,Chinese

Overview

A renowned expert in the field of breast tumors in China, a distinguished physician at Sun Yat-sen University, and Honorary Director of the Yixian Breast Tumor Hospital, he currently serves as the Director of the Breast Tumor Department at Guangzhou Taihe Cancer Hospital. With extensive clinical experience in breast tumors, he specializes in standardized, personalized, and comprehensive breast cancer treatment, possessing deep expertise in breast tumor surgery and full-spectrum disease management.

Current Hospital Appointments

HospitalRole
Guangzhou Concord Cancer CenterBreast Cancer Department

Academic & Professional Titles

  • Distinguished Senior Expert and Academic Leader in Breast Surgery, Guangzhou Taihe Cancer Hospital
  • Honorary President, Yixian Breast Tumor Hospital
  • Renowned Physician, Sun Yat-sen University
  • Chief Expert for Guangdong Province, National Breast Cancer Screening Program for One Million Women
  • Founder and Inaugural Chairperson, Breast Disease Branch of the Guangdong Medical Association
  • Founder and Inaugural Chairperson, Breast Specialist Branch of the Guangdong Medical Doctor Association
  • Member, Breast Cancer Professional Committee of the China Anti-Cancer Association

Clinical Expertise

  • Early screening and diagnosis of breast tumors, surgical treatment of breast cancer
  • personalized comprehensive diagnosis and treatment of breast cancer
  • full-continuum management of breast tumors
  • full-continuum management of breast tumors,
  • Leading the way in high breast-conserving surgery rates: The team achieves a nationwide-leading breast conservation rate (50%–57%), with patients undergoing breast-conserving surgery attaining a 10-year disease-free survival rate of 91%.

Research & Publications

  • Author: New Concepts Driving Therapeutic Transformation
  • Author: The Impact of Novel Molecular Technologies on Breast Cancer Treatment
  • Author: Impact of Tumor Size on Cosmetic Outcome After Breast-Conserving Surgery
  • Author: Comparative Study of Immunohistochemistry between Preoperative Core Needle Biopsy and Surgical Resection Specimens in Breast Cancer

Honours & Awards

  • Acclaimed as a "Renowned National Physician," he is a leading expert in the diagnosis and treatment of breast tumors in China.
  • Recognized as a "Renowned Physician of Sun Yat-sen University."

Contact Me

    Hi, How Can We Help You?
    LOADING